Sleep deprivation induces amyloid beta peptide and phosphorylated tau deposits in the brain and cerebrospinal fluid together with altered serotonin metabolism. Thus, it is likely that sleep deprivation is one of the predisposing factors in precipitating Alzheimer's disease (AD) brain pathology. Our previous studies indicate significant brain pathology following sleep deprivation or AD. Keeping these views in consideration in this review, nanodelivery of monoclonal antibodies to amyloid beta peptide (AβP), phosphorylated tau (p-tau), and tumor necrosis factor alpha (TNF-α) in sleep deprivation-induced AD is discussed based on our own investigations. Our results suggest that nanowired delivery of monoclonal antibodies to AβP with p-tau and TNF-α induces superior neuroprotection in AD caused by sleep deprivation, not reported earlier.
Keywords: Alzheimer’s disease; Brain pathology; Monoclonal antibodies; Nanomedicine amyloid beta peptide; Nanowired delivery; Neuroprotection; Phosphorylated p-tau; Serotonin6 receptor antagonist; Sleep deprivation.
© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.